| 摘要 |
PURPOSE: An anticancer agent composition containing oyster hydrolysate is provided to be used in a pharmaceutical product and health functional foods without toxicity and side effect. CONSTITUTION: An anticancer agent composition contains peptides isolated from oyster protein hydrolysate as an active ingredient. A method for preparing the oyster protein hydrolysate comprises: a step of dissolving freeze-dried oyster in a buffer solution; a step of adding hydrolase to the solution; a step of heating the hydrolysate in hot water; and a step of filtering, concentrating, and drying the hydrolysate. The buffer solution is a phosphate buffer or glycine-HCl buffer. The protease is flavourzyme, neutrase, papain, pepsin, trypsin, alpha-chyotrypsin, alcalase, or protamex. |
